Release of pseudosyndactyly in recessive dystrophic epidermolysis bullosa using a dermal regeneration template glove: the Foggia experience
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1172
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Release of pseudosyndactyly in recessive dystrophic epidermolysis bullosa using a dermal regeneration template glove: the Foggia experience ; volume:16 ; number:1 ; day:28 ; month:1 ; year:2021 ; pages:1-9 ; date:12.2021
Orphanet journal of rare diseases ; 16, Heft 1 (28.1.2021), 1-9, 12.2021
- Creator
-
Lembo, Fedele
Parisi, Domenico
Cecchino, Liberato Roberto
Ciancio, Francesco
Innocenti, Alessandro
Portincasa, Aurelio
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13023-021-01697-5
- URN
-
urn:nbn:de:101:1-2021032121203399089195
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 5:20 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lembo, Fedele
- Parisi, Domenico
- Cecchino, Liberato Roberto
- Ciancio, Francesco
- Innocenti, Alessandro
- Portincasa, Aurelio
- SpringerLink (Online service)
Other Objects (12)
STAT3 targeting in dystrophic epidermolysis bullosa
Dystrophic epidermolysis bullosa - from biochemistry to interventions
Mesenchymal stromal cell therapy for dystrophic epidermolysis bullosa
Biomechanics and epidermal barrier disruption in dystrophic epidermolysis bullosa
Deconstructing progressive inflammatory fibrosis in recessive dystrophic epidermolysis bullosa
Dystrophic epidermolysis bullosa: secondary disease mechanisms and disease modifiers
Pain in recessive dystrophic epidermolysis bullosa (RDEB): findings of the Prospective Epidermolysis Bullosa Longitudinal Evaluation Study (PEBLES)
Splicing modulation via antisense oligonucleotides in recessive dystrophic epidermolysis bullosa
Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms
Systemic collagen VII replacement therapy for advanced recessive dystrophic epidermolysis bullosa
Recessive dystrophic epidermolysis bullosa caused by a novel COL7A1 variant with isodisomy
EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa
STAT3 targeting in dystrophic epidermolysis bullosa
Dystrophic epidermolysis bullosa - from biochemistry to interventions
Mesenchymal stromal cell therapy for dystrophic epidermolysis bullosa
Biomechanics and epidermal barrier disruption in dystrophic epidermolysis bullosa
Deconstructing progressive inflammatory fibrosis in recessive dystrophic epidermolysis bullosa
Dystrophic epidermolysis bullosa: secondary disease mechanisms and disease modifiers
Pain in recessive dystrophic epidermolysis bullosa (RDEB): findings of the Prospective Epidermolysis Bullosa Longitudinal Evaluation Study (PEBLES)
Splicing modulation via antisense oligonucleotides in recessive dystrophic epidermolysis bullosa
Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms
Systemic collagen VII replacement therapy for advanced recessive dystrophic epidermolysis bullosa
Recessive dystrophic epidermolysis bullosa caused by a novel COL7A1 variant with isodisomy
EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa
STAT3 targeting in dystrophic epidermolysis bullosa
Dystrophic epidermolysis bullosa - from biochemistry to interventions
Mesenchymal stromal cell therapy for dystrophic epidermolysis bullosa
Biomechanics and epidermal barrier disruption in dystrophic epidermolysis bullosa
Deconstructing progressive inflammatory fibrosis in recessive dystrophic epidermolysis bullosa
Dystrophic epidermolysis bullosa: secondary disease mechanisms and disease modifiers
Pain in recessive dystrophic epidermolysis bullosa (RDEB): findings of the Prospective Epidermolysis Bullosa Longitudinal Evaluation Study (PEBLES)
Splicing modulation via antisense oligonucleotides in recessive dystrophic epidermolysis bullosa
Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms
Systemic collagen VII replacement therapy for advanced recessive dystrophic epidermolysis bullosa
Recessive dystrophic epidermolysis bullosa caused by a novel COL7A1 variant with isodisomy